Arrhythmia is a potentially life-threatening problem with the rate or rhythm of the heartbeat, causing it to go too fast, too slow or to beat irregularly. Arrhythmia affects millions of people worldwide.
The cardiac conduction system (CCS) regulates the rate and rhythm of the heart. It is a group of specialized cells in the walls of the heart. These cells control the heart rate by sending electrical signals from the sinoatrial node in the heart’s right atrium (upper chamber) to the ventricles (lower chambers), causing them to contract and pump blood.
The biologic and genetic mechanisms controlling the formation and function of the CCS are not well understood, but new research with mice shows that altered function of a gene called Tbx3 interferes with the development of the CCS and causes lethal arrhythmias.
In a study published in the Dec. 26, 2011, Proceedings of the National Academy of Sciences early edition, researchers led by the University of Utah showed CCS is extremely sensitive to levels of Tbx3. Mouse embryos with Tbx3 levels below a critical threshold suffered arrhythmia and couldn’t survive. As the levels of Tbx3 were increased, mice survived to birth, but as adults they developed arrhythmias or had sudden death.
“Tbx3 dysfunction merits further investigation as a cause of acquired and spontaneous arrhythmias.” – Anne M. Moon MD Professor Pediatrics U School of Medicine
“The cardiac conduction system is very sensitive to Tbx3,” Moon says. “Tbx3 is required for the conduction system to develop, mature, and then continue to function properly,” Moon said.
The Tbx3 protein, which is a transcription factor encoded by the TBX3 gene, has been linked to heart development, but its role is not yet clearly defined. Moon and her colleagues, including first author Deborah U. Frank, M.D., Ph.D., U assistant professor of pediatrics, found that slight alterations in the structure of the Tbx3 gene alter the level of the protein in mice. When this happens, it can impair the electrical signal in the sinoatrial node and block the atrioventricular node, which conducts electrical signals from the atria to the ventricles. The result is lethal arrhythmias in embryonic and adult mice.
This discovery has implications for the potential to regenerate functional heart tissue, according to Moon. “There’s a big effort to regenerate heart muscle,” she says. “But if the muscle can’t conduct electrical signals, it’s not going to do any good; we also need to be able to regenerate conduction tissues to regulate that muscle.”
Arrhythmia is not the first problem related to mutations in the TBX3 gene. In humans, TBX3 mutations have been shown to cause limb malformations in people with ulnar-mammary syndrome, an inherited birth disorder characterized by abnormalities of the bones in the hands and forearms and underdeveloped sweat and mammary glands.
In her future research, Moon wants to discover specifically how Tbx3 regulates the behavior of cells in the cardiac conduction system and whether cells that don’t have enough Tbx3 die or turn into some other kind of cells.
Researchers at the University of Amsterdam, University of Washington, and New York University also contributed to the study.